Nara Shin is a pharmacist who is specialized in Pharmacotherapy in Apo, Armed Forces Pacific. Patients can reach her at Psc 444, Apo or contact her on 817-301-8910. Active license number of Nara Shin is 53805 for Pharmacotherapy in Texas. Nara Shin is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Nara Shin speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Nara Shin
Specialization:
Pharmacotherapy
Gender:
Female
Location:
Psc 444, Apo, Armed Forces Pacific, 96297-0020
Phone:
817-301-8910
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Nara Shin are as mentioned below.
NPI Number:
1104556034
NPI Enumeration Date:
14 Jun, 2022
NPI Last Update On:
14 Jun, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nara Shin are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
53805
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Psc 444 Box 1943, Apo, Armed Forces Pacific
Zip:
96297-0020
Phone Number:
--
Fax Number:
--
Patients can reach Nara Shin at Psc 444, Apo, Armed Forces Pacific or can call on phone at 817-301-8910.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.